Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Bad now on jobs but will get worse

Angiotensin receptor blockers do not have an adverse effect on risk of myocardial infarction, according to a new systematic review.

The study, published online by the BMJ, looked at 19 studies on 31,569 patients and concluded ARBs did not increase risk compared with placebo.

The Canadian researchers said the finding ‘may alleviate recent concerns over the safety of this class of medications'.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say